Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 23 May 2024 for Harvard Bioscience INC. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Thomas W. Loewald: trading record in brief
All filings by Thomas W. Loewald on record concern Harvard Bioscience Inc, in the capacity of board member. Over a trading history stretching from 25 May 2021 to 21 May 2024, the count stands at 6 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 23 May 2024, reports a share grant in Harvard Bioscience Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas W. Loewald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
45,872 shares0Common StockSEC:0000921895-24-001306:0
25,554 shares0Common StockSEC:0000921895-23-001328:0
38,259 shares0Common StockSEC:0000921895-22-001803:0
2,525 shares0Common StockSEC:0000921895-22-000033:0
1,401 shares0Common StockSEC:0000921895-21-002901:0
14,400 shares0Common StockSEC:0000921895-21-001512:0
6 of 6 declarations
